Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Chung
    Chung
  3. Kernan
    Kernan
  4. Landau
    Landau
  5. Scordo
    Scordo
  6. Shah
    Shah
  7. Hassoun
    Hassoun
  8. Hultcrantz
    Hultcrantz
  9. Korde
    Korde
  10. Lesokhin
    Lesokhin

Groups

  1. Pediatrics, Department of (6)
  2. Bone Marrow Transplant (5)
  3. Center for Hematologic Malignancies (5)
  4. Department of Medicine (5)
  5. Hematologic Malignancies, Division of (5)
  6. CTCR Scholars (3)
  7. Stem Cell Transplantation and Cellular Therapy Service (3)
  8. Survivorship Research (3)
  9. GME, Medicine (2)
  10. Graduate Medical Education (2)
Search Within
  1. "Meeting abstract"
  2. "Pediatrics, Department of"
  3. "Clinical Lymphoma, Myeloma and Leukemia"
Formats
  1. Meeting Abstract (6)
Groups
  1. Pediatrics, Department of (6)
  2. Bone Marrow Transplant (5)
  3. Center for Hematologic Malignancies (5)
  4. Department of Medicine (5)
  5. Hematologic Malignancies, Division of (5)
  6. CTCR Scholars (3)

More Groups

People
  1. Sergio Giralt (5)
  2. David Chung (3)
  3. Gunjan Shah (3)
  4. Heather Landau (3)
  5. Kinga Hosszu (3)
  6. Michael Scordo (3)

More People

Years
  1. 2023 (3)
  2. 2017 (3)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of defibrotide to treat hepatic veno-occlusive disease/sinusoidal obstruction Syndrome (VOD/SOS) After Primary Chemotherapy: A post hoc analysis of final data from an expanded-access protocol
    Meeting Abstract

    Kernan, N.; Antin, J.; Messinger, Y.; Liang, W.; Hume, R.; Tappe, W.; Richardson, P.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Timing of initiation of defibrotide post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol
    Meeting Abstract

    Richardson, P.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; Tappe, W.; Kernan, N.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Day+100 survival and safety results from a defibrotide expanded-access program for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS): Final results
    Meeting Abstract

    Kernan, N.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; Tappe, W.; Richardson, P.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save